http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003516994-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2000-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2003516994-A |
| titleOfInvention | Substituted 1,2,3-triazolo [1,5-a] quinazolines for improving cognitive ability |
| abstract | (57) The present invention provides compounds of formula (I) for improving cognitive performance in conditions such as Alzheimer's disease, wherein R 1 is generally hydrogen or CF 3 , and R 2 is generally hydrogen. Wherein W is a cyclic amine, a heterocycle, or a group that is LYX (where LY is a linking moiety and X is generally an aromatic or non-aromatic heterocycle, alkyl, or alkylcarbonyl) And Z is generally a heterocycle such as 5-methylisoxazol-3-yl] and pharmaceutically acceptable salts thereof, and pharmaceutical compositions containing them, their use in the manufacture of medicaments, Methods of treatment using these are provided. Embedded image |
| priorityDate | 1999-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 211.